Congenital anomalies in cerebral palsy: where to from here?

Sarah McIntyre1,2, Eve Blair2, Shona Goldsmith1

  • 1Cerebral Palsy Alliance, The University of Sydney, Sydney, NSW, Australia.

Insights

Congenital anomalies are present in 15-40% of cerebral palsy (CP) cases. Improving data linkage between CP and anomaly registers is crucial for understanding and potentially preventing CP, especially for anomalies caused by teratogens.

Area of Science:

  • Medical research
  • Public health
  • Epidemiology

Background:

  • 15-40% of cerebral palsy (CP) cases involve congenital anomalies, which are highly variable.
  • Existing CP registers often lack comprehensive congenital anomaly data, hindering research.
  • Linking CP and congenital anomaly registers is complex due to inconsistent data and definitions.

Purpose of the Study:

  • To highlight the need for improved data quality and linkage between cerebral palsy and congenital anomaly registers.
  • To explore the potential for primary prevention of CP through the prevention of congenital anomalies.
  • To identify challenges and considerations for data linkage and classification of anomalies in CP research.

Main Methods:

  • Review of data quality in Australian CP registers regarding congenital anomalies.
  • Discussion of historical and potential future classification systems for congenital anomalies in CP.
  • Analysis of the complexities and limitations in linking different types of health registers.

Main Results:

  • Significant variability in congenital anomalies associated with CP.
  • Identified deficiencies in congenital anomaly data within CP registers.
  • Complexity in data linkage due to lack of unified processes and definitions across registers.

Conclusions:

  • Enhanced data linkage between CP and congenital anomaly registers is essential for accurate research.
  • Primary prevention of some CP cases may be achievable by preventing specific congenital anomalies, particularly those linked to teratogens.
  • Global collaboration is necessary to study subgroups of CP with congenital anomalies due to their low prevalence.

Related Concept Videos

Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
47.3K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Direct Motor Pathways01:11

Direct Motor Pathways

The direct motor pathways, also known as the pyramidal tracts, are a group of neural pathways that originate in the brain and descend through the spinal cord. They control the voluntary movement of the body. There are two major direct motor pathways: the corticospinal and the corticobulbar tracts.
The corticospinal tract is responsible for the voluntary movement of the limbs and trunk. It originates in the cerebral cortex of the brain and descends through the cerebrum's internal capsule and...
5.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K